News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Brooks John L. III
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
4
| Brooks John L. III (Director) has filed a Form 4 on iSpecimen Inc.|
Txns:
| Granted 125 shares
@ $0 |
|
| 02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Brooks John L (Director) has filed a Form 4 on iSpecimen Inc.|
Txns:
| Granted 10,000 options
@ $1.41, valued at
$14.1k
|
|
| 02/14/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/23/2011 |
3
| Brooks John L (Director) has filed a Form 3 on Pathfinder Cell Therapy, Inc. |
| 05/18/2007 |
4
| Brooks John L (10% Owner) has filed a Form 4 on INSULET CORP|
Txns:
| Converted 190,352 shares
@ $0
Converted 190,352 shares
@ $0
Converted 720,253 shares
@ $0
Converted 1,087,730 shares
@ $0
Converted 796,626 shares
@ $0
Converted 627,537 shares
@ $0
Converted 500,000 convertible preferred
@ $0
Converted 500,000 convertible preferred
@ $0
Converted 1,891,892 convertible preferred
@ $0
Converted 2,857,143 convertible preferred
@ $0
Converted 2,092,500 convertible preferred
@ $0 |
|
|
|